1. Zimmer Biomet saw $1.89 billion in net sales in the first quarter of 2024, a 3.2% increase from the year prior.
2. The company’s net earnings for the first quarter of 2024 hit $172.4 million.
3. Zimmer Biomet’s restructuring program, which included a 3% reduction in staff, has been implemented with no major disruptions, CEO Ivan Tornos said.
4. ZimVie, Zimmer Biomet’s spine and dental spinoff, closed on the sale of its spine business to global investment firm H.I.G. Capital. The spine business now operates as Highridge Medical, based in Westminster, Colo.
5. Zimmer Biomet earned FDA clearance for the Rosa Shoulder robot.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
